Literature DB >> 20493857

Telomeres and telomerase in normal and cancer stem cells.

Jerry W Shay1, Woodring E Wright.   

Abstract

Differences between normal adult tissue stem cells and cancer stem/initiating cells remain poorly defined. For example, it is controversial if cancer stem cells can become fully quiescent, require a stem cell niche, are better at repairing DNA damage than the bulk of the cancer cells, and if and how they regulate symmetric versus asymmetric cell divisions. This minireview will not only provide our personal views to address some of these outstanding questions, but also present evidence that an understanding of telomere dynamics and telomerase activity in normal and cancer stem cells may provide additional insights into how tumors are initiated, and how they should be monitored and treated. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493857      PMCID: PMC3370416          DOI: 10.1016/j.febslet.2010.05.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  42 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Authors:  Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics.

Authors:  Joshua R Merok; Janice A Lansita; James R Tunstead; James L Sherley
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 4.  Historical claims and current interpretations of replicative aging.

Authors:  Woodring E Wright; Jerry W Shay
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

5.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

6.  Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

Authors:  Alan K Meeker; Jessica L Hicks; Elizabeth A Platz; Gerrun E March; Christina J Bennett; Michael J Delannoy; Angelo M De Marzo
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

7.  Segregation of sister chromatids in mammalian cells.

Authors:  K G Lark; R A Consigli; H C Minocha
Journal:  Science       Date:  1966-12-02       Impact factor: 47.728

8.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression.

Authors:  A T Collins; F K Habib; N J Maitland; D E Neal
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

10.  Intestinal stem cells protect their genome by selective segregation of template DNA strands.

Authors:  Christopher S Potten; Gary Owen; Dawn Booth
Journal:  J Cell Sci       Date:  2002-06-01       Impact factor: 5.285

View more
  87 in total

1.  An enhanced H/ACA RNP assembly mechanism for human telomerase RNA.

Authors:  Emily D Egan; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2012-04-23       Impact factor: 4.272

2.  Roles of telomerase reverse transcriptase N-terminal domain in assembly and activity of Tetrahymena telomerase holoenzyme.

Authors:  Barbara Eckert; Kathleen Collins
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

3.  Oncogene-induced senescence results in marked metabolic and bioenergetic alterations.

Authors:  Celia Quijano; Liu Cao; Maria M Fergusson; Hector Romero; Jie Liu; Sarah Gutkind; Ilsa I Rovira; Robert P Mohney; Edward D Karoly; Toren Finkel
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 4.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

5.  Early Detection of Oral Squamous Cell Carcinoma (OSCC) - Role of Genetics: A Literature Review.

Authors:  C Seethalakshmi
Journal:  J Clin Diagn Res       Date:  2013-08-01

6.  Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells.

Authors:  Eva Majerová; Miloslava Fojtová; Iva Mozgová; Miroslava Bittová; Jiří Fajkus
Journal:  Plant Mol Biol       Date:  2011-08-25       Impact factor: 4.076

Review 7.  The non-canonical functions of telomerase: to turn off or not to turn off.

Authors:  Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Totoń; Natalia Lisiak; Hanna Hołysz; Anna Królak; Sylwia Grodecka-Gazdecka; Błażej Rubiś
Journal:  Mol Biol Rep       Date:  2018-11-17       Impact factor: 2.316

8.  Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Authors:  Manjie Xing; Wen Fong Ooi; Jing Tan; Aditi Qamra; Po-Hsien Lee; Zhimei Li; Chang Xu; Nisha Padmanabhan; Jing Quan Lim; Yu Amanda Guo; Xiaosai Yao; Mandoli Amit; Ley Moy Ng; Taotao Sheng; Jing Wang; Kie Kyon Huang; Chukwuemeka George Anene-Nzelu; Shamaine Wei Ting Ho; Mohana Ray; Lijia Ma; Gregorio Fazzi; Kevin Junliang Lim; Giovani Claresta Wijaya; Shenli Zhang; Tannistha Nandi; Tingdong Yan; Mei Mei Chang; Kakoli Das; Zul Fazreen Adam Isa; Jeanie Wu; Polly Suk Yean Poon; Yue Ning Lam; Joyce Suling Lin; Su Ting Tay; Ming Hui Lee; Angie Lay Keng Tan; Xuewen Ong; Kevin White; Steven George Rozen; Michael Beer; Roger Sik Yin Foo; Heike Irmgard Grabsch; Anders Jacobsen Skanderup; Shang Li; Bin Tean Teh; Patrick Tan
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

9.  Chromosome arm-specific long telomeres: a new clonal event in primary chronic myelogenous leukemia cells.

Authors:  Oumar Samassekou; Huiyu Li; Josée Hébert; Aimé Ntwari; Haixia Wang; Catherine Grenier Cliché; Eric Bouchard; Shiang Huang; Ju Yan
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

10.  Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.